PLK2 and Cognitive impairment: It is interesting to note that both Aβ and Plk2 cause synapse loss, a process which is strongly associated with cognitive impairment in AD [3], while pharmacological inhibition of Plk2 function ameliorates synapse loss and memory decline in an aggressive mouse model of AD.